|
Biotech Business
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 415 articles |
 Page 6 of 6 
|
PARATEK GETS PATENT FOR REDUCING MICROBIAL RESISTANCE TO DRUGS.
September 01, 2002
INOSINE IMPROVES FUNCTION IN ANIMALS AFTER STROKE.
August 01, 2002
NATIONAL CANCER INSTITUTE TO CONDUCT DIMERICINE CLINICAL TRIAL.
August 01, 2002
AVANT GETS PATENT FOR CHOLESTEROL MANAGEMENT VACCINE.
August 01, 2002
CERUS EXPANDS PATENT COVERAGE FOR PATHOGEN INACTIVATION.
August 01, 2002
EXACT SCIENCES/LABCORP TO OFFER NON-INVASIVE COLORECTAL TEST.
August 01, 2002
MICROISLET ADDS NEW PATENT FOR ENCAPSULATION OF ISLET CELLS.
July 01, 2002
MILLENNIUM'S MLN341 EFFECTIVE AGAINST MULTIPLE MYELOMA.
July 01, 2002
NEW CLASS OF CYCLOSPORIN ANALOGS ARE ANTI-INFLAMMATORY.
July 01, 2002
LAWRENCE LIVERMORE FINDS UNIQUE ANTHRAX DNA SIGNATURES.
July 01, 2002
BIOMARIN INITIATES PHASE 2 CLINICAL TRIAL OF ARYPLASE.
June 01, 2002
GENEFORMATICS AIDS INCYTE ANNOTATE PROTEIN SEQUENCE FUNCTIONS.
June 01, 2002
HOLLIS-EDEN REPORTS HE2500 REDUCES PARALYSIS FROM EAE.
June 01, 2002
DENDREON GETS ORPHAN DRUG STATUS FROM FDA FOR MYLOVENGE.
June 01, 2002
INTERLEUKIN MAPS NOVEL SNP FOR KEY INFLAMMATION GENE.
June 01, 2002
DYAX GETS EXCLUSIVE RIGHTS RELATED TO INFLAMMATION TARGET.
May 01, 2002
CYTOGENIX GETS RESEARCH GRANT FROM NIH.
May 01, 2002
FDA GRANTS AVICENA ORPHAN-DRUG DESIGNATION FOR CREATINE.
May 01, 2002
DURECT/CARDINAL TO DEVELOP GEL-CAP PRODUCTS USING SABER.
May 01, 2002
KOSAN GETS SBIR GRANT FOR PRODUCTION OF POLYKETIDES.
May 01, 2002
LARGE SCALE BIOLOGY ISSUED PATENT FOR NEW PLANT SPECIES.
May 01, 2002
CHIRON'S PROCLEIX HIV-1/HCV ASSAY RECEIVES FDA APPROVAL.
April 01, 2002
ACHILLION INITIATES PHASE 2 STUDY OF HEPATITIS B TREATMENT.
April 01, 2002
PALATIN REPORTS POSITIVE PT-141 PHASE 1 CLINICAL RESULTS.
April 01, 2002
SKINMEDICA DEBUTS TNS RECOVERY COMPLEX FOR AGING SKIN.
April 01, 2002
MEDAREX/ZYCOS SIGN PACT TO DEVELOP HUMAN ANTIBODY THERAPEUTICS.
March 01, 2002
VIACELL TO BEGIN CLINICAL TRIAL FOR SELECTIVE AMPLIFICATION.
March 01, 2002
UNIVERSITIES COMMERCIALIZE TECHNOLOGY TO RE-SENSITIZE BACTERIA.
March 01, 2002
IVAX GETS FINAL APPROVAL FOR METFORMIN.
March 01, 2002
RADIANCE COMPLETES ENROLLMENT IN BRITE II CLINICAL STUDY.
February 01, 2002
BIOSANTE REPORTS POSITIVE ORAL INSULIN STUDY RESULTS.
February 01, 2002
PEREGRINE INITIATES ANTIBODY GENERATION AGAINST 2 TARGETS.
February 01, 2002
GERON GRANTED U.S. PATENT FOR EMBRYONIC GERM CELLS.
February 01, 2002
GENENTECH GRANTED PATENT FOR FUNDAMENTAL ANTIBODY TECHNOLOGY.
February 01, 2002
FDA APPROVES TRACLEER PULMONARY HYPERTENSION DRUG.
February 01, 2002
NEOPHARM GETS ORPHAN DRUG STATUS FOR IL13-PE38.
January 01, 2002
IMMTECH DISCOVERS ORAL TREATMENT FOR TYPE 2 DIABETES.
January 01, 2002
REGENERON INITIATES CLINICAL TRIAL OF VEGF TRAP IN CANCER.
January 01, 2002
ENDOVASC STUDY SHOWS NICOTINE MAY HELP GROW HEART BYPASSES.
January 01, 2002
AVICINE PROVIDES SURVIVAL BENEFIT FOR PANCREATIC CANCER.
January 01, 2002
|
